ArticleMedical science monitor : international medical journal of experimental and clinical research2025
A New Perspective on NSTE-ACS Patients in the Emergency Department: Cardiac Risk Prediction with New Inflammation Markers.
Article in Medical science monitor : international medical journal of experimental and clinical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The systemic immune-inflammation index in coronary heart disease: a narrative review of thromboinflammation, phenotype-dependent utility, and clinical translation.Frontiers in cardiovascular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Acute coronary syndromes (ACS) remains a leading cause of death worldwide. The use of inflammation biomarkers has recently become quite popular in understanding both the severity and prognosis of cardiovascular diseases. The aim of this study was to investigate the association of pan-immune-inflammation value (PIV) with the risk of in-hospital MACE assessed by the GRACE risk score (GRS) in patients diagnosed with NSTE-ACS. MATERIAL AND METHODS A total of 489 patients were admitted to the Emergency Department (ED) of our hospital with chest pain and hospitalized in the coronary intensive care unit and diagnosed with NSTE-ACS. PIV was calculated as: neutrophil count times platelet count times monocyte count divided by lymphocyte count. RESULTS Of the patients included in this study, 91 (18.6%) had low GRS, 183 (37.4%) had intermediate GRS, and 215 (44%) had high GRS. The inflammatory markers PIV, SII, and NLR were found to be statistically significantly higher in the MACE (+) groups (P<0.001). ROC curve analysis showed 82% sensitivity and 84% specificity in detecting MACE for a cut-off value of 756.03 for PIV (area under the receiver operating characteristics [ROC] curve 0.86 [95% CI: 0.82-0.89], P<0.001). CONCLUSIONS Inflammatory markers such as PIV were found to be statistically significantly higher in the MACE (+) groups of NSTE-ACS patients. Moreover, there was a statistically significant correlation between PIV value and GRS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.